237 related articles for article (PubMed ID: 16266359)
61. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
[TBL] [Abstract][Full Text] [Related]
62. Safety and efficacy of topical anesthesia combined with a lower concentration of intracameral lidocaine in phacoemulsification: paired human eye study.
Chuang LH; Yeung L; Ku WC; Yang KJ; Lai CC
J Cataract Refract Surg; 2007 Feb; 33(2):293-6. PubMed ID: 17276272
[TBL] [Abstract][Full Text] [Related]
63. Flecainide for the treatment of chronic neuropathic pain: a Phase II trial.
von Gunten CF; Eappen S; Cleary JF; Taylor SG; Moots P; Regevik N; Cleeland C; Cella D
Palliat Med; 2007 Dec; 21(8):667-72. PubMed ID: 18073252
[TBL] [Abstract][Full Text] [Related]
64. Topical lignocaine for pain relief in acute otitis media: results of a double-blind placebo-controlled randomised trial.
Bolt P; Barnett P; Babl FE; Sharwood LN
Arch Dis Child; 2008 Jan; 93(1):40-4. PubMed ID: 18156478
[TBL] [Abstract][Full Text] [Related]
65. A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection.
Youle M; Osio M;
HIV Med; 2007 May; 8(4):241-50. PubMed ID: 17461852
[TBL] [Abstract][Full Text] [Related]
66. Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules.
Nicholson B; Ross E; Weil A; Sasaki J; Sacks G
Curr Med Res Opin; 2006 Mar; 22(3):539-50. PubMed ID: 16574037
[TBL] [Abstract][Full Text] [Related]
67. Transdermal fentanyl reduces pain and improves functional activity in neuropathic pain states.
Agarwal S; Polydefkis M; Block B; Haythornthwaite J; Raja SN
Pain Med; 2007; 8(7):554-62. PubMed ID: 17883740
[TBL] [Abstract][Full Text] [Related]
68. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study.
Galer BS; Rowbotham MC; Perander J; Friedman E
Pain; 1999 Apr; 80(3):533-538. PubMed ID: 10342414
[TBL] [Abstract][Full Text] [Related]
69. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing.
Gammaitoni AR; Davis MW
Ann Pharmacother; 2002 Feb; 36(2):236-40. PubMed ID: 11847940
[TBL] [Abstract][Full Text] [Related]
70. Evaluation and treatment of painful peripheral polyneuropathy.
Singleton JR
Semin Neurol; 2005 Jun; 25(2):185-95. PubMed ID: 15937734
[TBL] [Abstract][Full Text] [Related]
71. The effect of mirtazapine in patients with chronic pain and concomitant depression.
Freynhagen R; Muth-Selbach U; Lipfert P; Stevens MF; Zacharowski K; Tölle TR; von Giesen HJ
Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
[TBL] [Abstract][Full Text] [Related]
72. Insufficient evidence to recommend topical lidocaine as first-line treatment for postherpetic neuralgia.
Zakrzewska JM
Evid Based Dent; 2007; 8(3):85-6. PubMed ID: 17891129
[TBL] [Abstract][Full Text] [Related]
73. Does nebulized lidocaine reduce the pain and distress of nasogastric tube insertion in young children? A randomized, double-blind, placebo-controlled trial.
Babl FE; Goldfinch C; Mandrawa C; Crellin D; O'Sullivan R; Donath S
Pediatrics; 2009 Jun; 123(6):1548-55. PubMed ID: 19482767
[TBL] [Abstract][Full Text] [Related]
74. Use of lidocaine patch 5% for chronic low back pain: a report of four cases.
Hines R; Keaney D; Moskowitz MH; Prakken S
Pain Med; 2002 Dec; 3(4):361-5. PubMed ID: 15099246
[TBL] [Abstract][Full Text] [Related]
75. Polyneuropathy, with and without neurogenic pain, and its impact on daily life activities--a descriptive study.
Liedberg GM; Vrethem M
Disabil Rehabil; 2009; 31(17):1402-8. PubMed ID: 19479570
[TBL] [Abstract][Full Text] [Related]
76. Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: a multicentre, randomized, assessor-blinded study.
Jensen TS; Høye K; Fricová J; Vanelderen P; Ernault E; Siciliano T; Marques S
Eur J Pain; 2014 Oct; 18(9):1240-7. PubMed ID: 24664539
[TBL] [Abstract][Full Text] [Related]
77. Efficacy and safety of 5% lidocaine-medicated plasters in localized pain with neuropathic and/or inflammatory characteristics: an observational, real-world study.
Amato F; Duse G; Consoletti L; Lo Presti C; Firetto V; Ciliberto G; Parigi LA; Palmieri V; Mazza M
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4228-4235. PubMed ID: 29028074
[TBL] [Abstract][Full Text] [Related]
78. A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study.
Nalamachu S; Crockett RS; Gammaitoni AR; Gould EM
MedGenMed; 2006 Aug; 8(3):33. PubMed ID: 17406167
[TBL] [Abstract][Full Text] [Related]
79. [Reduction of chronic pain for non-postherpetic peripheral neuropathies after topical treatment with a lidocaine patch].
Meier T; Faust M; Hüppe M; Schmucker P
Schmerz; 2004 Jun; 18(3):172-8. PubMed ID: 15221421
[TBL] [Abstract][Full Text] [Related]
80. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
